Management

  • Michel Pettigrew
    Michel Pettigrew

    President of the Executive Board & Chief Operating Officer, Ferring Group

  • Michel Pettigrew

    Mr. Pettigrew joined Ferring in May 2001. In addition to his role as President of the Executive Board, he is responsible for all Commercial, Global Marketing, Business Development, Medical Services, Technical Operations and Research activities of the Company. He is also President and CEO of Ferring Holding US, Ferring's largest subsidiary, and is responsible for all Clinical Development and Commercial activities in the United States. Prior to his arrival at Ferring, Mr. Pettigrew held several senior management positions throughout the world during a 21-year career with Bristol-Myers Squibb. Michel L. Pettigrew has a Bachelor of Commerce degree from McGill University in Montreal and an MBA from York University in Toronto, Canada.

    Some description

  • Pascal Danglas
    Pascal Danglas

    Executive Vice President, Clinical and Product Development

  • Pascal Danglas

    Dr. Danglas has responsibility for all activities associated with the development of Ferring medicines and their registration globally. Dr. Danglas has a Medical Degree from the University of Paris, a CPA (Business Administration Degree) and CESAM (Statistical Degree). His vast pharmaceutical experience includes leading positions with M.S.D., Bayer and AKZO Research Center. From 1995 to 2003 Pascal Danglas was General Manager of Ferring France.

    Some description

  • Peter Wilden
    Peter Wilden

    Chief Financial Officer and Executive Vice President

  • Peter Wilden

    Dr. Peter Wilden joined Ferring in 1991 coming from the IT & Management Consulting sector. He has occupied several leading posts within the company and became Chief Financial Officer in 2000. Dr. Wilden has a profound background in corporate taxation. He holds a degree in Business Administration and Information Technology from the University of Kiel, as well as a Ph.D. in Business Administration. Since 2004 Dr. Wilden is member of the Board of Directors and Chairman of the Audit & Compliance Committee of Lonza Group AG, Basel.

    Some description

  • Jean Duvall
    Jean Duvall

    Group General Counsel & Secretary to the Board of Directors

  • Jean Duvall

    Ms. Jean Duvall joined Ferring in November 2006. She is responsible for all legal activities on a global basis and is also the Secretary to the Board of Directors. Prior to her arrival at Ferring, Ms. Duvall was General Counsel at Elan Corporation, plc. Jean Duvall has a Bachelor of Science degree from Case Western Reserve University and a Juris Doctor degree from Ohio State University.

    Some description

UK office

Ferring Pharmaceuticals Ltd.
Drayton Hall, Church Road, West Drayton.
UB7 7PS

Telephone : +44(0)8449310050

Contact

Global Locator

Corporate Global Locator

You are now leaving www.Ferring.co.uk , a website of Ferring Pharmaceuticals Ltd UK. Links to all outside websites are provided as a resource to our visitors. Ferring Pharmaceuticals Ltd accepts no responsibility for the content of other websites.